反応式
COc1nc(N)ncc1Br.FC(F)(F)c1cccc(I)c1>CC(=O)O.CC(=O)O.Cc1ccccc1.O=C([O-])[O-].[Cs+].[Cs+].[Pd].c1ccc(P(c2ccccc2)c2ccc3ccccc3c2-c2c(P(c3ccccc3)c3ccccc3)ccc3ccccc23)cc1>COc1nc(Nc2cccc(C(F)(F)F)c2)ncc1Br参加物
反応物 2
生成物 1
試薬・触媒・溶媒 4
反応条件
- 温度
- 80 °C
実験手順
_EN06995-11\Reaction_ and many others **_Aim:-_ prepare target for further use.** 1-iodo-3-(trifluoromethyl)benzene (0.215 ml, 1.49 mmol), 5-bromo-4-methoxypyrimidin-2-amine (0.254 g, 1.24 mmol), PALLADIUM(II) ACETATE (0.014 g, 0.06 mmol), rac-2,2'-bis(diphenylphosphino)-1,1'-binaphthalene (0.054 g, 0.09 mmol) and cesium carbonate (0.487 g, 1.49 mmol) were mixed in toluene (5ml), purged with nitrogen and stirred in a sealed tube at 80 °C overnight. LCMS: pH = 3, 2 minute run time, Rt = 0.66 min (32% by UV), m/z: 204 (MH+) \- 316 (M-H-) - ?; Rt = 1.10 min (15% by UV), m/z: 257, 306 (MH+) - 316 (M-H-) - ?; Rt = 1.28 min (25% by UV), m/z: 350, (MH+) product ?. The reaction mixture was diluted with EtOAc (20 ml), filtered through a celite pad and concentrated to give 902 mg yellow oil. TLC (1:1 - EtOAc : n-heptane) see diagram UV only This was disolved in DCM, absorbed onto a samplet and purified on a 10 g Biotage SNAP column (approx column volume = 7 ml), eluting with a step-wise gradient from 0 : 10 to 4 : 6 EtOAc : n-heptane using a Thomson pump collecting 12 ml fractions. F1 - y = 38 mg - GCMS and NMR - show it to be product F2 - y = 229 mg \- GCMS and NMR - show it to be bromo SM **_Conclusion:_ \- ** Abandoned - to be repeated with xanphos
出典と根拠
- ORDレコード
- ord-971b196dec9043e8982df95c855b9cba
- 出典データセット
- 750 AstraZeneca ELN dataset
- 元リンク
- 出典を表示
関連ノート
読み込み中…